ROIV — Roivant Sciences Ltd.
Materials · Pharmaceutical Preparations · Nasdaq
3Insiders filing
11Transactions
+$1.3MReported buys
−$13.1MReported sells
0Cluster events
Insiders
| Insider | Role | Txns | Reported value |
|---|---|---|---|
| Sukhatme Mayukh | President & CIO | 9 | $13.7M |
| Venker Eric | President & Immunovant CEO | 1 | $512k |
| Pulik Richard | CFO | 1 | $212k |
Transaction history
| Filing date | Trade date | Ticker | Insider | Type | Shares | Price | Value | Cluster |
|---|---|---|---|---|---|---|---|---|
| 2026-08-21 | 2026-08-21 | ROIV | Sukhatme Mayukh President & CIO | M routine | 144,756 | $3.85 | +$557k | |
| 2026-08-21 | 2026-08-21 | ROIV | Sukhatme Mayukh President & CIO | S | 144,756 | $36.48 | −$5.3M | |
| 2026-08-21 | 2026-08-21 | ROIV | Sukhatme Mayukh President & CIO | M routine | 144,756 | — | — | |
| 2026-08-24 | 2026-08-20 | ROIV | Pulik Richard CFO | F routine | 5,749 | $36.84 | −$212k | |
| 2026-08-24 | 2026-08-20 | ROIV | Venker Eric President & Immunovant CEO | F routine | 13,909 | $36.84 | −$512k | |
| 2026-08-21 | 2026-08-20 | ROIV | Sukhatme Mayukh President & CIO | M routine | 17,519 | $3.85 | +$67k | |
| 2026-08-21 | 2026-08-20 | ROIV | Sukhatme Mayukh President & CIO | S | 17,519 | $37.30 | −$653k | |
| 2026-08-21 | 2026-08-20 | ROIV | Sukhatme Mayukh President & CIO | M routine | 17,519 | — | — | |
| 2026-08-21 | 2026-08-19 | ROIV | Sukhatme Mayukh President & CIO | M routine | 172,899 | $3.85 | +$666k | |
| 2026-08-21 | 2026-08-19 | ROIV | Sukhatme Mayukh President & CIO | S | 172,899 | $37.17 | −$6.4M | |
| 2026-08-21 | 2026-08-19 | ROIV | Sukhatme Mayukh President & CIO | M routine | 172,899 | — | — |
No transactions match these filters.